Home › NDC Lookup › RxCUI directory › RxCUI 2717083

0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe [Imuldosa] — RxCUI 2717083

Name: 0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe [Imuldosa] (RxCUI 2717083)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2717083 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2717083

Official name0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe [Imuldosa]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asImuldosa 45 MG per 0.5 ML Prefilled Syringe; IMULDOSA 45 MG in 0.5 ML Prefilled Syringe

FDA products mapped3

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ustekinumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Ustekinumab is approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active u...
What conditions does ustekinumab treat, and is it right for me?
It depends on your condition. For Crohn's disease and ulcerative colitis, the first dose is given as an IV infusion in a clinical setting. After that, you switch to under-the-skin...
How is ustekinumab given, and will I need to go to a clinic every time?

📖 Read our full Ustekinumab Injection guide →

🕸️ Concept Web — How 0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe [Imuldosa] RxCUI 2717083 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Ustekinumab 847083 IN
- Ustekinumab-srlf 2717063 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Imuldosa 2717069 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ustekinumab Prefilled Syringe 853349 SCDF
- Ustekinumab-srlf Prefilled Syringe 2717077 SCDFP
- Ustekinumab Injectable Product 1163983 SCDG
- Ustekinumab-srlf Injectable Product 2717065 SCDGP
- Ustekinumab Prefilled Syringe [Imuldosa] 2717081 SBDF
- Ustekinumab-srlf Prefilled Syringe [Imuldosa] 2717082 SBDFP
- Imuldosa Injectable Product 2717071 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe 2717078 SCD
- Ustekinumab-srlf 90 MG/ML 2717076 SCDC
- Ustekinumab-srlf 90 MG/ML [Imuldosa] 2717080 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.5 ML ustekinumab-srlf 90 MG/ML Prefilled Syringe SCD · 2717078
Ustekinumab-srlf 90 MG/ML SCDC · 2717076
Ustekinumab Prefilled Syringe SCDF · 853349
Ustekinumab-srlf Prefilled Syringe SCDFP · 2717077
Ustekinumab Injectable Product SCDG · 1163983
Ustekinumab-srlf Injectable Product SCDGP · 2717065

Brand-Name Concepts

Ustekinumab-srlf 90 MG/ML [Imuldosa] SBDC · 2717080
Ustekinumab Prefilled Syringe [Imuldosa] SBDF · 2717081
Ustekinumab-srlf Prefilled Syringe [Imuldosa] SBDFP · 2717082
Imuldosa Injectable Product SBDG · 2717071
Imuldosa BN · 2717069

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2717083 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
69448-0017-63	1 BLISTER PACK in 1 CARTON (69448-017-63) / 1 SYRINGE in 1...	IMULDOSA	Accord BioPharma Inc.	2024-10-14
69448-0018-63	1 BLISTER PACK in 1 CARTON (69448-018-63) / 1 SYRINGE in 1...	IMULDOSA	Accord BioPharma Inc.	2024-10-14
69448-0019-26	1 VIAL, SINGLE-USE in 1 CARTON (69448-019-26) / 26 mL in 1...	IMULDOSA	Accord BioPharma Inc.	2024-10-18

Observed labelers: Accord BioPharma Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5098	Inj ustekinumab-srlf, 1 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.